PRESS RELEASE published on 01/17/2024 at 08:00, 1 year 11 months ago Revolutionizing Drug Development: Novigenix Unveils AI-Powered RNA Analysis for Immune Response Profiling Novigenix, a leader in AI healthcare solutions, is launching LITOSeek™, a revolutionary innovation that utilizes advanced AI and RNA analysis to reshape cancer care and expedite drug development. Leveraging precision immunology, Novigenix is set to empower biopharma companies and transform cancer treatment paradigms, offering a breakthrough in personalized cancer treatment. With a team of over 20 Ph.D.-level scientists dedicated to advancing next-generation liquid biopsy solutions, Novigenix is at the forefront of pioneering precision immunology for superior patient outcomes. Novigenix LITOSeek AI Healthcare Solutions Precision Immunology Cancer Care
Published on 12/19/2025 at 18:30, 1 hour 41 minutes ago Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Published on 12/19/2025 at 14:40, 5 hours 31 minutes ago Northern Superior Announces Closing of the Arrangement
Published on 12/19/2025 at 13:30, 6 hours 41 minutes ago Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF
Published on 12/19/2025 at 13:30, 6 hours 41 minutes ago DataMetrex Announces Closing of Yuzu Payment Processing Solution Acquisition
Published on 12/19/2025 at 13:30, 6 hours 41 minutes ago Sterling Metals Provides Year End Update to Stakeholders
Published on 12/19/2025 at 19:56, 14 minutes ago Original-Research: European Lithium Limited (von First Berlin Equity Research GmbH): Buy
Published on 12/19/2025 at 19:00, 1 hour 11 minutes ago HIAG sells sites and properties as part of its sharpened corporate strategy and gains Swiss Post as a new tenant in Winterthur
Published on 12/19/2025 at 18:29, 1 hour 41 minutes ago clearvise AG commissions Triticum agri-photovoltaic project
Published on 12/19/2025 at 18:29, 1 hour 41 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 12/19/2025 at 08:30, 11 hours 41 minutes ago Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 11 hours 41 minutes ago Réduction du capital par voie d’annulation d’actions propres
Published on 12/19/2025 at 07:00, 13 hours 11 minutes ago EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Published on 12/19/2025 at 07:00, 13 hours 11 minutes ago EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION
Published on 12/18/2025 at 18:30, 1 day 1 hour ago Schneider Electric completes transaction to acquire remaining 35% stake in existing Indian JV